Iodine-131 given for therapeutic purposes modulates differently interferon-γ inducible chemokine CXCL10 serum levels in patients with active Graves’ disease or with toxic nodular goiter - Antonelli, A; Rotondi, M; Fallahi, P; Grosso, M; Boni, G; Ferrari, S M; Romagnani, P; Serio, M; Mariani, G; Ferrannini, E (J Clin Endocrinol Metab, 2007)